Quadria Capital
Healthcare
Flashback 2017: Pharma M&As hog limelight; multi-speciality hospitals get PE money
Large private equity investments in multi-specialty hospitals and sustained investor interest across the single-specialty space were the showstoppers in the ......
Healthcare
Is home healthcare sector still the heartthrob of investors?
In April, private equity firm Mahindra Partners led a $21-million funding round in home healthcare services provider Medwell Ventures Pvt. ......
Consumer
Capricorn Food explores IPO to let PE investor IBOF exit
Food pulp manufacturer Capricorn Food Products India Ltd is considering a public listing to allow India Build-Out Fund to exit ......
Healthcare
Company watch: Concord Biotech eyes new opportunities after Quadria's backing
Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20 years ago to start his entrepreneurial journey. The Ahmedabad-based biotechnology ......
Healthcare
Why PEs, VCs are holding back from investing in the stem cell market
In 2009, when eight-year-old Thamirabarani was cured of thalassaemia, a rare blood disorder, LifeCell International Pvt. Ltd made ripples in ......
Healthcare
Healthcare assets' valuation high in India, Southeast Asia: Quadria's Abrar Mir
Singapore- and India-based private equity firm Quadria Capital Investment Advisors Pvt. Ltd has deployed almost its entire $304 million debut ......
Healthcare
How scalable are IVF firms for PE/VC investments amid regulatory uncertainty?
Just a couple of months after the Cabinet approved a bill to ban commercial surrogacy, two contrasting developments occurred in ......
Healthcare
Kedaara Capital scraps talks to buy into RG Stone; other PE firms in fray
Private equity firm Kedaara Capital has called off negotiations to acquire India Equity Partners’ (IEP) stake in RG Stone Urology ......







